Quote | Vallon Pharmaceuticals Inc. (NASDAQ:VLON)
Last: | $0.40 |
---|---|
Change Percent: | 8.7% |
Open: | $0.42 |
Close: | $0.40 |
High: | $0.4308 |
Low: | $0.3803 |
Volume: | 1,082,726 |
Last Trade Date Time: | 04/21/2023 03:00:00 am |
News | Vallon Pharmaceuticals Inc. (NASDAQ:VLON)
Combined company will operate as GRI Bio , Inc. and advance i nnovative p ipeline of Natural Killer T ( “ NKT ” ) modulating therapies for the treatment of i nflammatory, f ibrotic and a utoimmune d ...
2023-04-21 03:00:05 ET Vallon Pharmaceuticals ( NASDAQ: VLON ) stockholders have approved proposed merger with GRI Bio, a privately held biotechnology company, at a special meeting of stockholders held on April 20, 2023. Based on a closing price of Vallon’s common s...
Message Board Posts | Vallon Pharmaceuticals Inc. (NASDAQ:VLON)
Subject | By | Source | When |
---|---|---|---|
Help me out but what does Therelink have | rakp | investorshub | 04/20/2023 10:46:05 AM |
Ther stock..its Meme with so many good news | Jayzp | investorshub | 04/19/2023 3:47:05 PM |
znewcar1: $VLON 25% v2,7M c.44 f13,482M H.5401 ML.32 LL.2054 | znewcar1 | investorshangout | 04/05/2023 9:53:27 PM |
znewcar1: $VLON 21% v1,9M c.48 f13,482M H.520 ML.32 LL.2054 | znewcar1 | investorshangout | 03/16/2023 10:20:47 PM |
Pick me up @ .70 | OffTheGrid | investorshub | 03/06/2023 8:21:01 PM |
News, Short Squeeze, Breakout and More Instantly...
Vallon Pharmaceuticals Inc. Company Name:
VLON Stock Symbol:
NASDAQ Market:
Combined company will operate as GRI Bio , Inc. and advance i nnovative p ipeline of Natural Killer T ( “ NKT ” ) modulating therapies for the treatment of i nflammatory, f ibrotic and a utoimmune d ...
Vallon’s b oard approves 1-for-30 r everse stock split Merger expected to close April 21, 2023 PHILADELPHIA, PA, April 20, 2023 (GLOBE NEWSWIRE) -- Vallon Pharmaceuticals, Inc. (NASDAQ: VLON) (“Vallon” or the “Company”) toda...
Board of Directors unanimously recommend Vallon stockholders to vote “ FOR ” all proposals outlined in the Company’s definitive Proxy Statement (the “Proxy”) in order to close the proposed merger with GRI Bio , Inc. ...